1. Home
  2. MMI vs MDXG Comparison

MMI vs MDXG Comparison

Compare MMI & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MMI

Marcus & Millichap Inc.

HOLD

Current Price

$27.82

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$7.23

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMI
MDXG
Founded
1971
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
MMI
MDXG
Price
$27.82
$7.23
Analyst Decision
Sell
Buy
Analyst Count
2
1
Target Price
$29.00
$12.00
AVG Volume (30 Days)
364.5K
774.9K
Earning Date
11-07-2025
10-29-2025
Dividend Yield
1.78%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.27
Revenue
$751,284,000.00
$393,442,000.00
Revenue This Year
$11.94
$19.13
Revenue Next Year
$15.59
$2.11
P/E Ratio
N/A
$26.73
Revenue Growth
20.74
14.77
52 Week Low
$27.35
$5.79
52 Week High
$41.94
$9.71

Technical Indicators

Market Signals
Indicator
MMI
MDXG
Relative Strength Index (RSI) 36.79 56.44
Support Level $28.74 $6.62
Resistance Level $29.65 $7.06
Average True Range (ATR) 0.82 0.23
MACD -0.13 0.05
Stochastic Oscillator 13.28 91.11

Price Performance

Historical Comparison
MMI
MDXG

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: